Posts

Medical marijuana knowledge and attitudes amongst internal medicine residents

/by

Mounting evidence suggests the safety and efficacy of medical marijuana (MM) in treating chronic ailments, including chronic pain, epilepsy, and anorexia. Despite incremental use of medical and recreational cannabinoids, current limited evidence shows generalized unpreparedness of medical providers to discuss or recommend these substances to their patients. Herein, the present study aims to examine internal medicine residents’ knowledge of marijuana and their attitude towards its medical use.

Read more

Cannabinoid Hyperemesis Syndrome Survey and Genomic Investigation

/by

Cannabinoid hyperemesis syndrome (CHS) is a diagnosis of exclusion with intractable nausea, cy- clic vomiting, abdominal pain, and hot bathing behavior associated with ongoing tetrahydrocannabinol (THC) exposure. Increasing cannabis use may elevate CHS prevalence, exacerbating a public health issue with atten- dant costs and morbidity.

Read more

Trends in Cannabis Use Among Older Adults in the United States, 2015-2018.

/by

Authors: Benjamin H. Han, Joseph J. Palamar
JAMA Internal Medicine, 24 February 2020
—
With the legalization of cannabis in many states for medical and/or recreational purposes, there is increasing interest in using cannabis to treat a variety of long-term health conditions and symptoms common among older adults. The use of cannabis in the past year by adults 65…

Read more

Cocaine and Marijuana Use Among Young Adults With Myocardial Infarction.

/by

Authors: Ersilia M. DeFilippis, Avinainder Singh, Sanjay Divakaran, Ankur Gupta, Bradley L. Collins, et al
Journal of the American College of Cardiology, 5 June 2018
—
BACKGROUND: Substance abuse is increasingly prevalent among young adults, but data on cardiovascular outcomes remain limited. OBJECTIVES: The objectives of this study were to assess the prevalence of cocaine and marijuana use in adults with their first myocardial infarction (M…

Read more